Skip to content

Effect of Aerobic Interval Training on Cardiovascular Function in Aging

Effect of Aerobic Interval vs. Continuous Exercise Training on Cardiovascular Function in Aging

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01883271
Enrollment
60
Registered
2013-06-21
Start date
2013-05-31
Completion date
2019-02-21
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging

Brief summary

Study objectives: 1. To compare cardiovascular function in older compared to young healthy adults. 2. To compare the effect of 8 weeks of aerobic interval training vs. continuous moderate exercise on cardiovascular function in healthy older adults. Hypotheses: 1. Compared to young adults, older adults will have lower cardiovascular function. 2. Compared to continuous moderate intensity exercise training, interval training will be more effective in improving cardiovascular function in older adults.

Detailed description

Cardiovascular function will be measured at baseline in older healthy adults and young healthy controls. Older adults will be randomized to the aerobic interval training group, continuous moderate exercise group or non-exercise control group. At the end of the 8-week exercise intervention, baseline measures will be repeated in the older adults.

Interventions

Supervised aerobic interval training will be performed on bicycles 4 times per week for 8 weeks. Each training session will last 40 minutes and will consist of 10-minute warm up at 70% of maximal heart rate (HRmax), four 4-minute intervals at 90% of HRmax with 3-min active recovery at 70% of HRmax and 5-minute cool down at 70% of HRmax.

Supervised exercise training will be performed on bicycles 4 times per week for 8 weeks. Each training session will last 47 minutes and will consist of continuous moderate intensity cycling at 70% of HRmax.

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 79 Years
Healthy volunteers
Yes

Inclusion criteria

for older adults: * Healthy men and women 55 to 79 years of age * Sedentary or minimally physically active for at least the prior 1 year. * Women will be premenopausal or postmenopausal (either natural or surgical) defined as a cessation of menses for at least 2 years. * Premenopausal women will be eumenorrheic and will be studied during the early follicular phase (days 1 through 6) of the menstrual cycle. * Able to give consent. Inclusion Criteria for young adults: * Healthy men and women 18 to 35 years of age * Sedentary or minimally physically active for at least the prior 1 year. * Women will be premenopausal, eumenorrheic and will be studied during the early follicular phase (days 1 through 6) of the menstrual cycle. * Able to give consent.

Exclusion criteria

* history of diabetes * history of any relevant cardiovascular diseases (myocardial infarction, angina pectoris, history of coronary artery bypass surgery or angioplasty, congestive heart failure, or arrhythmia) * hypertension (≥160 mmHg systolic or ≥100 mmHg diastolic) * history of renal impairment * history of gout or hyperuricemia * history of hepatic disease or infection with hepatitis B, C * history of seizures, or other relevant on-going or recurrent illness * recent (within 3 months) or recurrent hospitalizations * use of tobacco products * \>5 % weight change in the prior 6 months. * current intake of medications that may affect study results * participation in regular aerobic exercise training (\>30 minutes, * 3 times/wk in the past year). * premenopausal women taking oral contraceptives and postmenopausal women taking hormone replacement therapy. * pregnancy (positive urine pregnancy test) or lactation

Design outcomes

Primary

MeasureTime frameDescription
Change in vascular endothelial functionAt baseline and after 8 weeks of exercise trainingBrachial flow-mediated dilation using ultrasonography

Secondary

MeasureTime frameDescription
Change in factors related with endothelial functionAt baseline and after 8 weeks of exercise trainingBlood and cellular markers of oxidative stress and inflammation
Change in arterial stiffnessAt baseline and after 8 weeks of exercise trainingArterial stiffness and wave reflection will be measured using the SphygmoCor device
Change in cardiac functionAt baseline and after 8 weeks of exercise trainingLeft ventricular systolic and diastolic function will be measured using echocardiography
Change in maximal oxygen consumptionAt baseline and after 8 weeks of exercise trainingMaximal oxygen consumption will be measured using online computer-assisted open-circuit spirometry during incremental treadmill exercise

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026